“The North American spine surgery devices market is expected to register a CAGR of 7.5%, with the U.S. having the maximum market share. This region is estimated to grow at a CAGR of 7.3%.
The market, by product type, encompasses spinal fusion and fixation devices, spine biologics devices, VCF treatment devices, non-fusion implant devices, and spine bone stimulators devices. Of these, the spinal fusion and fixation devices segment is the largest and fastest-growing segment.
Key players focus on securing FDA approvals to launch their products in the market. For instance Alphatec Spine, Inc. announced that its new product, the AlphaTec Solus, had received regulatory approval from the FDA. The addition of this new product expanded the company鈥檚 portfolio of total bone constructs.
The report shares a competitive view of various companies in the market, in terms of the geographies they operate in, revenue bifurcation, and their market shares. The report provides brief insights about the current scenario in the market and its future prospects.
Key players in this market include Alphatec Spine, Inc. (U.S.), Biomet, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Integra LifeSciences (U.S.).
“
